G1 Therapeutics
0 followers
G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development and delivery of next generation therapies that improve the lives of those affected by cancer, including the Company’s first commercial product, COSELA™ (Trilaciclib).
Org chart
Jack Bailey
CEO
Jack Bailey
Collapse
Andrew Perry
Chief Commercial Officer
Mark Avagliano
Chief Business Officer
Raj Malik
Chief Medical Officer
Monica Thomas
General Counsel & Chief Compliance Office
Whitney Page
Chief Of Staff And Senior Director Of Corporate Development
Symantha Melemed
Sr Vice President- Development
Amanda Jacobson
Senior Director Clinical Science
Shellie Pressley
Associate Director, Product Development Outsourcing
Monica R.
General Counsel, Corporate Secretary and Chief Compliance Officer
Annie McCoy
Associate Director, Statistical Programming
Olu O. Oyeneye
Sr Infrastructure /DevOps Eng.
Mike Townsend
Principal Solutions Architect
